JBCHEPHARM.BOJBCHEPHARM.BOBSE
Loading
Operating Income ScalingExpanding
Percentile Rank100
3Y CAGR+60.8%
5Y CAGR+43.2%
Year-over-Year Change
Profit from core business operations before interest and taxes
3Y CAGR
+60.8%/yr
vs +28.7%/yr prior
5Y CAGR
+43.2%/yr
Recent acceleration
Acceleration
+32.0pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
6x
Strong expansion
Streak
7 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $19.14B | +153.8% |
| 2024 | $7.54B | +29.0% |
| 2023 | $5.85B | +26.9% |
| 2022 | $4.60B | +1.1% |
| 2021 | $4.56B | +43.2% |
| 2020 | $3.18B | +23.2% |
| 2019 | $2.58B | +54.1% |
| 2018 | $1.68B | -27.1% |
| 2017 | $2.30B | +10.1% |
| 2016 | $2.09B | - |